These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3500755)

  • 21. Measurement of stimulated dopamine release in the rat by in vivo voltammetry: the influence of stimulus duration on drug responses.
    Stamford JA; Kruk ZL; Millar J
    Neurosci Lett; 1986 Aug; 69(1):70-3. PubMed ID: 3748467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of increases in impulse flow.
    Tepper JM; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):309-16. PubMed ID: 6089959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nigroamygdaloid dopamine neurons: nigral modulation of their activity.
    Leviel V; Charriere B; Fayada C; Guibert B
    Brain Res; 1986 Sep; 381(2):205-14. PubMed ID: 3019477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time measurement of dopamine release in rat brain.
    Kuhr WG; Wightman RM
    Brain Res; 1986 Aug; 381(1):168-71. PubMed ID: 3489505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo electrochemical evidence for simultaneous 5-HT and histamine release in the rat substantia nigra pars reticulata following medial forebrain bundle stimulation.
    Hashemi P; Dankoski EC; Wood KM; Ambrose RE; Wightman RM
    J Neurochem; 2011 Sep; 118(5):749-59. PubMed ID: 21682723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.
    Juorio AV; Paterson IA; Zhu MY; Matte G
    J Neurochem; 1991 Jan; 56(1):213-20. PubMed ID: 1670953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic neurons: reversal of effects elicited by gamma-butyrolactone by stimulation of the nigro-neostriatal pathway.
    Murrin LC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):15-20. PubMed ID: 12482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of the subthalamic nucleus enhances the release of dopamine in the rat substantia nigra.
    Mintz I; Hammond C; Guibert B; Leviel V
    Brain Res; 1986 Jun; 376(2):406-8. PubMed ID: 3730844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute nigro-striatal blockade alters cortico-striatal encoding: an in vivo electrophysiological study.
    Prosperetti C; Di Giovanni G; Stefani A; Möller JC; Galati S
    Exp Neurol; 2013 Sep; 247():730-6. PubMed ID: 23537952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal dopamine terminals release serotonin after 5-HTP pretreatment: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Brain Res; 1990 May; 515(1-2):173-80. PubMed ID: 2357555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic terminal excitability following arrival of the nerve impulse: the influence of amphetamine and haloperidol.
    Takeuchi H; Young SJ; Groves PM
    Brain Res; 1982 Aug; 245(1):47-56. PubMed ID: 6288195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of dopaminergic influence on striatal-nigral neurotensin systems.
    Letter AA; Matsuda LA; Merchant KM; Gibb JW; Hanson GR
    Brain Res; 1987 Sep; 422(1):200-3. PubMed ID: 3119151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Voltammetric study of extracellular dopamine near microdialysis probes acutely implanted in the striatum of the anesthetized rat.
    Borland LM; Shi G; Yang H; Michael AC
    J Neurosci Methods; 2005 Aug; 146(2):149-58. PubMed ID: 15975664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity-dependent changes in substantia nigra gamma-aminobutyric acid.
    Swift RM; Hoffmann PC; Heller A
    Brain Res; 1978 Nov; 156(1):181-6. PubMed ID: 308835
    [No Abstract]   [Full Text] [Related]  

  • 38. Theory for the impact of basal turnover on dopamine clearance kinetics in the rat striatum after medial forebrain bundle stimulation and pressure ejection.
    Michael AC; Borland LM; Mitala JJ; Willoughby BM; Motzko CM
    J Neurochem; 2005 Sep; 94(5):1202-11. PubMed ID: 15992374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term depression in striatal dopamine release monitored by in vivo voltammetry in free moving rats.
    Abraini JH; Raharison L; Rostain JC
    Brain Res; 1991 May; 548(1-2):256-9. PubMed ID: 1678298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral activation in rats increases striatal dopamine metabolism measured by dialysis perfusion.
    Salamone JD; Keller RW; Zigmond MJ; Stricker EM
    Brain Res; 1989 May; 487(2):215-24. PubMed ID: 2786443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.